Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol

@article{Tamaya1986GestrinoneB,
  title={Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol},
  author={Teruhiko Tamaya and Jiro Fujimoto and Y. Watanabe and Keiko Arahori and Hiroji Okada},
  journal={Acta Obstetricia et Gynecologica Scandinavica},
  year={1986},
  volume={65}
}
To understand the mechanism of biological action of gestrinone (R2323), which has a therapeutic effect against endometriosis, the binding of gestrinone to numerous classes of intracellular steroid binding proteins was studied in the human uterine endometrium. Gestrinone bound to endometrial receptors for estrogen, progesterone and androgen, but seemed not to bind to endometrial intracellular corticosteroid‐binding globulin and sex hormone‐binding globulin. Gestrinone occupies all specific… Expand
Tetrahydrogestrinone is a potent androgen and progestin.
TLDR
It is demonstrated that THG is a highly potent androgen and progestin in a yeast-based in vitro bioassay system expressing human androgens and progesterone receptors and has no estrogenic activity, antagonism for any of the three steroid receptor classes. Expand
Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus.
TLDR
Gestrinone dose of 60 micrograms (2.5 mg of clinical dose) every 3 days is considered to be effective for anti-steroid action in sex steroid receptor dynamics in the rabbit uterus, contributing to the rationale for gestrinone treatment of pelvic endometriosis. Expand
Multicentre study of gestrinone in cyclical breast pain FRIEDOLF PETERS
TLDR
Gestrinone was very effective in the treatment of cyclical mastalgia and was well tolerated and serum concentrations of oestradiol, progesterone, and tri-iodothyronine were significantly lower than baseline after 3 months of gestrinone. Expand
Medical Treatments for Endometriosis-Associated Pelvic Pain
TLDR
The first-line treatment for endometriosis associated pain is still represented by oral contraceptives used continuously, butgestins represent an acceptable alternative and norethisterone acetate at low dosage should be preferred. Expand
Preparation and Chromatographic Characterization of Tetrahydrogestrinone, a New “Designer” Anabolic Steroid
Tetrahydrogestrinone (THG, (17α)-13β-ethyl-17β-hydroxy-18,19-dinorpregna-4,9,11-trien-3-one, C21H28O2, 312 m.w.) is a synthetic 19-norsteroid closely related to gestrinoneExpand
Determination and excretion study of gestrinone in human urine by high performance liquid chromatography and gas chromatography/mass spectrometry.
TLDR
The reproducibility of the derivatization method was stable and recoveries were over 87% when spiked into blank urine. Expand
Designer Androgens in Sport: When Too Much Is Never Enough
The recent identification of tetrahydrogestrinone (THG), the first true "designer androgen," as a sports doping agent reflects both an alarmingly sophisticated illicit manufacturing facility and anExpand
Treatment of pelvic endometriosis with gestrinone--report on 9 cases.
Nine patients with pelvic endometriosis were treated with gestrinone in a dose of 2.5 mg twice weekl- for 6 to 7 months. All patients became anovulator- with sporadic episodes of painless uterineExpand
Determination of the metabolites of gestrinone in human urine by high performance liquid chromatography, liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry.
TLDR
The trimethylsilyl (TMS)-enol-TMS ether derivative of gestrinone displayed three peaks in its GC/MS chromatogram, formed by tautomerism. Expand
History of Endometriosis : A 20 th-Century Disease
A reconstruction of the history of progress made in identifying, describing, and treating the condition we call endometriosis is neither simple nor easy because for almost 90 years endometriosis andExpand
...
1
2
...

References

SHOWING 1-10 OF 15 REFERENCES
Binding of progesterone and R 5020, a highly potent progestin, to human endometrium and myometrium.
TLDR
The affinity and specificity of labelled R 5020 binding to the "7–8S" component have been determined by equilibrium dialysis on total cytosol and were further characterized by crossed competition studies following ammonium sulfate precipitation. Expand
Mechanism of antiprogestational action of synthetic steroids.
TLDR
Data suggest that such a synthetic steroid binds to a P receptor, and the steroid-receptor complex enters into the nucleus but does not activate the chromatin template, thus resulting in the antiprogestational effect. Expand
Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity.
TLDR
Controversy continues as the whether danazol possesses progestational, antiprogestational, or no progestations effects. Expand
Comparison of tritium-labeled steroids for progesterone receptor assay in human endometrium.
TLDR
It is suggested that it is better not to use a tritium-labeled steroid with the same steroid as a competitor in order to get a non-specific binder for the measurement of progesterone receptor assay. Expand
The serum transport of steroid hormones.
TLDR
This chapter discusses the serum transport of steroid hormones, where the steroid-receptor complex apparently moves into the nucleus where it modifies the chromatin transcriptional activity which results in altered levels of protein synthesis. Expand
Screening for anti-hormones by receptor studies.
TLDR
The primary advantage of running studies in parallel on several receptors resides in the possibility of classifying the anti-hormones according to whether they possess affinity for a given receptor, thus providing a criterion for the selection of highly specific compounds virtually devoid of hormonal side-effects. Expand
Action of midcycle contraceptive (R 2323) on the human endometrium.
TLDR
It would appear that R 2323 acts as a temporary substitute for progesterone at the receptor level but that it does not induce all the biological manifestations of this hormone, in particular, the endometrial changes required for implantation. Expand
Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone.
  • E. Coutinho
  • Medicine
  • American journal of obstetrics and gynecology
  • 1982
TLDR
Twenty patients with endometriosis diagnosed by laparoscopy were treated with the antiestrogen, antiprogesterone gestrinone (R-2323) for 6 to 8 months and three women who had the potential and the desire to conceive, three conceived within 3 months after termination of treatment. Expand
Comparison of tritium - labelled steroids for progesterone receptor as
  • Asia - Oceania J Obstet Gynecol
  • 1982
Comparison of tritium-labelled steroids for progesterone receptor assay
  • Asia-Oceania J Obstet Gynecol
  • 1982
...
1
2
...